-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Dw17PUtd6p65F52UCT1/hfFAVr3wkCYAiAzxNOSUn1SpHJJrS207Mskj1+n6WfnC q7WHLq0y2NLugbKo06TLmA== 0000950123-09-023715.txt : 20090721 0000950123-09-023715.hdr.sgml : 20090721 20090721095154 ACCESSION NUMBER: 0000950123-09-023715 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20090720 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20090721 DATE AS OF CHANGE: 20090721 FILER: COMPANY DATA: COMPANY CONFORMED NAME: IDEX CORP /DE/ CENTRAL INDEX KEY: 0000832101 STANDARD INDUSTRIAL CLASSIFICATION: PUMPS & PUMPING EQUIPMENT [3561] IRS NUMBER: 363555336 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-10235 FILM NUMBER: 09954285 BUSINESS ADDRESS: STREET 1: 630 DUNDEE RD STE 400 CITY: NORTHBROOK STATE: IL ZIP: 60062 BUSINESS PHONE: 8474987070 8-K 1 c52444e8vk.htm FORM 8-K FORM 8-K
 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of report: July 20, 2009
(Date of earliest event reported)
IDEX CORPORATION
(Exact name of registrant as specified in its charter)
         
Delaware
(State of
Incorporation)
  1-10235
(Commission File Number)
  36-3555336
(IRS Employer
Identification No.)
630 Dundee Road
Northbrook, Illinois 60062

(Address of principal executive offices, including zip code)
(847) 498-7070
(Registrant’s telephone number, including area code)
     Check the appropriate box if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o   Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o   Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o   Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o   Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 


 

Item 2.02 — Results of Operations and Financial Condition.
On July 20, 2009, IDEX Corporation (the “Company”) issued a press release announcing financial results for the second quarter ended June 30, 2009.
A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.
The information in this Current Report furnished pursuant to Item 2.02 shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section. This information shall not be incorporated by reference into any registration statement pursuant to the Securities Act of 1933, as amended.
Item 9.01 — Financial Statements and Exhibits.
(d) Exhibits
     
99.1
  Press release dated July 20, 2009 announcing IDEX Corporation’s second quarter operating results

 


 

SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
         
  IDEX CORPORATION
 
 
  By:   /s/ Dominic A. Romeo    
    Dominic A. Romeo   
    Vice President and Chief Financial Officer   
 
July 21, 2009

 


 

Exhibit Index
     
Exhibit    
Number  
Description
99.1
  Press release dated July 20, 2009 announcing IDEX Corporation’s second quarter operating results

 

EX-99.1 2 c52444exv99w1.htm EX-99.1 EX-99.1
EXHIBIT 99.1
IDEX CORPORATION REPORTS SECOND QUARTER 2009 RESULTS;
ADJUSTED EARNINGS PER SHARE OF 37 CENTS
NORTHBROOK, IL, July 20 — IDEX Corporation (NYSE: IEX) today announced second quarter 2009 results.
New orders in the quarter totaled $319 million, down 21 percent compared to the prior-year period. Sales in the quarter totaled $336 million, 15 percent lower than the prior-year period.
Adjusted operating margin was 14.9 percent, down 320 basis points from the prior-year period, primarily due to lower volume. Second quarter reported operating income of $47 million was 35 percent lower than the prior-year period and included the impact of charges related to restructuring ($3.3M). Reported operating margin of 13.9 percent reflected a 420 basis point decline versus the prior-year period.
Excluding the 3 cents per share impact of restructuring-related charges, diluted earnings per share was 37 cents, a decline of 17 cents, or 31 percent, from the second quarter of the previous year. Reported net income of $28 million decreased 38 percent versus the second quarter of the previous year. Reported diluted earnings per share of 34 cents declined 20 cents, or 37 percent, from the second quarter of the previous year.
Second Quarter 2009 Results
  Orders decreased 21 percent compared to the prior year (+5 percent acquisitions, -22 organic and -4 percent foreign currency translation).
  Sales decreased 15 percent compared to the prior year (+6 percent acquisitions, -17 organic and -4 percent foreign currency translation).
  Net income was $28 million, or 38 percent lower than the prior year. Excluding restructuring-related charges, net income was $30 million, or 33 percent lower than the prior year.
  Diluted EPS of 34 cents was 20 cents, or 37 percent, lower than the prior year. Excluding restructuring-related charges, diluted EPS of 37 cents was 17 cents, or 31 percent, lower than the prior year.
  EBITDA of $61 million was 18 percent of sales and covered interest expense by 14 times.
  Free cash flow of $50 million includes the estimated annual $6M contribution to pension plans and represents 180 percent of net income.

“We are pleased with our second quarter results given the current market environment. Our team is focused on growing market share during the downturn and we continue to find new opportunities to reinvest in the business. At the same time, we are proving that our operating model enables us to both flex our cost structure and continue to generate cash. Operating margin of 15 percent and free cash generation at 180 percent of net income are both respectable achievements for the quarter.
We expect that energy, water, and select health and science end markets will modestly improve in the second half of 2009; however we also expect that industrial process and dispensing end markets will remain challenged for the balance of the year.
Given the current conditions and assuming no economic recovery in the second half, we expect third quarter EPS in the range of 33 to 37 cents on a fully diluted basis. For the full year, we project organic revenue to decline approximately 15 percent resulting in adjusted diluted EPS of $1.35 to $1.45.”
Lawrence D. Kingsley
Chairman and Chief Executive Officer

 


 

Business Highlights (excluding restructuring-related charges)
Fluid & Metering Technologies
¡   Sales in the second quarter of $157 million reflected a 12 percent decline compared to the second quarter of 2008 (+11 percent acquisitions, -20 percent organic and -3 percent foreign currency translation).
¡   Operating margin of 15.4 percent represented a 320 basis point decline compared with the second quarter of 2008. Excluding the impact of acquisitions, operating margin was 17.2 percent, a 140 basis point decline compared with the prior-year period due to lower sales.
Health & Science Technologies
¡   Sales in the second quarter of $74 million reflected a 15 percent decline compared to the second quarter of 2008 (+5 percent acquisitions, -18 percent organic and -2 percent foreign currency translation). The organic decline was primarily due to significant market softness in the non-core HST businesses.
¡   Operating margin of 15.7 percent reflected a 250 basis point decline compared with the second quarter of 2008. Excluding the impact of the Semrock acquisition, operating margin was 14.9 percent, a 330 basis point decline compared with the prior-year period due to lower sales.
Dispensing Equipment
¡   Sales of $46 million in the second quarter reflected a 19 percent decline compared with the second quarter of 2008 (-13 percent organic and -6 percent foreign currency translation), as a result of continued deterioration in capital spending for both the North American and European markets.
¡   Operating margin of 21.9 percent reflected a 330 basis point decline compared with the second quarter of 2008 due to lower volumes in Europe.
Fire & Safety/Diversified Products
¡   Sales in the second quarter of $62 million reflected a 20 percent decline compared with the second quarter of 2008 (-14 percent organic and -6 percent foreign currency translation).
¡   Operating margin of 22.1 percent represented a 230 basis point decline compared with the second quarter of 2008 on lower volumes and unfavorable product mix within the segment.
For the second quarter of 2009, Fluid & Metering Technologies contributed 46 percent of sales and 41 percent of operating income; Health & Science Technologies accounted for 22 percent of sales and 19 percent of operating income; Dispensing Equipment accounted for 14 percent of sales and 17 percent of operating income; and Fire & Safety/Diversified Products represented 18 percent of sales and 23 percent of operating income.
Conference Call to be Broadcast over the Internet
IDEX will broadcast its second quarter earnings conference call over the Internet on Tuesday, July 21, 2009 at 9:30 a.m. CT. Chairman and Chief Executive Officer Larry Kingsley and Vice President and Chief Financial Officer Dominic Romeo will discuss the company’s recent financial performance and respond to questions from the financial analyst community. IDEX invites interested investors to listen to the call and view the accompanying slide presentation, which will be carried live on its website at www.idexcorp.com. Those who wish to participate should log on several minutes before the discussion begins. After clicking on the presentation icon, investors should follow the instructions to ensure their systems are set up to hear the event and view the presentation slides, or download the correct applications at no charge. Investors will also be able to hear a replay of the call by dialing 888.203.1112 (or 719.457.0820 for international participants) using the ID # 6940348.
A Note on EBITDA and Free Cash Flow
EBITDA means earnings before interest, income taxes, depreciation and amortization, while free cash flow means cash flow from operating activities less capital expenditures plus the excess tax benefit from stock-based compensation. Management uses these non-GAAP financial measures as internal operating metrics and for enterprise valuation purposes. Management believes these measures are useful as analytical indicators of leverage capacity and debt servicing ability, and uses them to measure financial performance as well as for planning purposes. However, they should not be considered as alternatives to net income, cash flow from operating activities or any other items calculated in accordance with U.S. GAAP, or as an indicator of operating performance. The definitions of EBITDA and free cash flow used here may differ from those used by other companies.

 


 

EBITDA and Free Cash Flow bridge
                                                 
            For the Quarter Ended  
            June 30,               March 31,          
            2009     2008     Change     2009     Change  
Income before Taxes
          $ 41.9     $ 69.0       (39 )%   $ 34.1       23 %
Depreciation and Amortization
            14.2       12.2       16       13.6       4  
Interest
            4.4       4.1       9       4.8       (8 )
 
                                         
EBITDA
          $ 60.5     $ 85.3       (29 )   $ 52.5       15  
 
                                         
 
Cash Flow from Operating Activities
          $ 55.3     $ 64.7       (15 )%   $ 17.6       n/m %
Capital Expenditures
            (6.1 )     (6.9 )     (12 )     (4.9 )     26  
Excess Tax Benefit from Stock-Based Compensation
            0.6       2.2       (72 )     0.6        
 
                                         
Free Cash Flow
          $ 49.8     $ 60.0       (17 )   $ 13.3       n/m  
 
                                         
Forward-Looking Statements
This news release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Exchange Act of 1934, as amended. These statements may relate to, among other things, capital expenditures, cost reductions, cash flow, and operating improvements and are indicated by words or phrases such as “anticipate,” “estimate,” “plans,” “expects,” “projects,” “should,” “will,” “management believes,” “the company believes,” “the company intends,” and similar words or phrases. These statements are subject to inherent uncertainties and risks that could cause actual results to differ materially from those anticipated at the date of this news release. The risks and uncertainties include, but are not limited to, the following: economic and political consequences resulting from terrorist attacks and wars; levels of industrial activity and economic conditions in the U.S. and other countries around the world; pricing pressures and other competitive factors, and levels of capital spending in certain industries — all of which could have a material impact on order rates and IDEX’s results, particularly in light of the low levels of order backlogs it typically maintains; its ability to make acquisitions and to integrate and operate acquired businesses on a profitable basis; the relationship of the U.S. dollar to other currencies and its impact on pricing and cost competitiveness; political and economic conditions in foreign countries in which the company operates; interest rates; capacity utilization and the effect this has on costs; labor markets; market conditions and material costs; and developments with respect to contingencies, such as litigation and environmental matters. The forward-looking statements included here are only made as of the date of this news release, and management undertakes no obligation to publicly update them to reflect subsequent events or circumstances. Investors are cautioned not to rely unduly on forward-looking statements when evaluating the information presented here.
About IDEX
IDEX Corporation is an applied solutions company specializing in fluid and metering technologies, health and science technologies, dispensing equipment, and fire, safety and other diversified products built to its customers’ exacting specifications. Its products are sold in niche markets to a wide range of industries throughout the world. IDEX shares are traded on the New York Stock Exchange and Chicago Stock Exchange under the symbol “IEX”.
For further information on IDEX Corporation and its business units, visit the company’s Web site at
www.idexcorp.com.
(Tables follow)

 


 

IDEX CORPORATION
IDEX CORPORATION
Condensed Statements of Consolidated Operations
(in thousands except per share amounts)
                                 
    Three Months Ended     Six Months Ended  
    June 30,     June 30,  
    2009     2008 (a)     2009     2008 (a)  
 
Net sales
  $ 336,455     $ 397,310     $ 663,068     $ 768,972  
Cost of sales
    205,354       235,800       408,773       454,982  
 
Gross profit
    131,101       161,510       254,295       313,990  
Selling, general and administrative expenses
    81,116       89,400       162,898       176,468  
Restructuring expenses
    3,250             5,501        
 
Operating income
    46,735       72,110       85,896       137,522  
Other income (expense) — net
    (385 )     987       (576 )     1,162  
Interest expense
    4,440       4,092       9,261       9,758  
 
Income before income taxes
    41,910       69,005       76,059       128,926  
Provision for income taxes
    13,988       23,945       25,532       44,263  
 
Net income
  $ 27,922     $ 45,060     $ 50,527     $ 84,663  
 
 
Earnings per Common Share:
                               
Basic earnings per common share (b)
  $ 0.35     $ 0.55     $ 0.63     $ 1.03  
Diluted earnings per common share (b)
  $ 0.34     $ 0.54     $ 0.62     $ 1.02  
 
Share Data:
                               
Basic weighted average common shares outstanding
    79,675       81,322       79,594       81,194  
Diluted weighted average common shares outstanding
    80,507       82,746       80,363       82,511  
Condensed Consolidated Balance Sheets
(in thousands)
                 
    June 30,     December 31,  
    2009     2008 (a)  
 
Assets
               
Current assets
               
Cash and cash equivalents
  $ 67,916     $ 61,353  
Receivables — net
    200,995       205,269  
Inventories
    166,977       181,200  
Other current assets
    29,205       32,866  
 
Total current assets
    465,093       480,688  
Property, plant and equipment — net
    181,376       186,283  
Goodwill and intangible assets
    1,468,872       1,470,289  
Other noncurrent assets
    10,464       14,540  
 
Total assets
  $ 2,125,805     $ 2,151,800  
 
Liabilities and shareholders’ equity
               
Current liabilities
               
Trade accounts payable
  $ 75,221     $ 87,304  
Accrued expenses
    101,850       117,186  
Short-term borrowings
    7,038       5,856  
Dividends payable
    9,550       9,523  
 
Total current liabilities
    193,659       219,869  
Long-term borrowings
    500,845       548,144  
Other noncurrent liabilities
    230,278       239,004  
 
Total liabilities
    924,782       1,007,017  
Shareholders’ equity
    1,201,023       1,144,783  
 
Total liabilities and shareholders’ equity
  $ 2,125,805     $ 2,151,800  
 
-more-

 


 

IDEX CORPORATION
IDEX CORPORATION
Company and Business Group Financial Information
(dollars in thousands)
                                 
    Three Months Ended     Six Months Ended  
    June 30, (c)     June 30, (c)  
    2009     2008 (a)     2009     2008 (a)  
 
Fluid & Metering Technologies
                               
Net sales
  $ 157,000     $ 177,358     $ 314,018     $ 348,288  
Operating income (d)
    24,221       32,964       47,361       64,571  
Operating margin
    15.4 %     18.6 %     15.1 %     18.5 %
Depreciation and amortization
  $ 8,566     $ 6,450     $ 16,335     $ 12,763  
Capital expenditures
    3,315       2,785       5,872       5,176  
Health & Science Technologies
                               
Net sales
  $ 73,816     $ 87,247     $ 148,004     $ 170,889  
Operating income (d)
    11,603       15,865       22,110       30,884  
Operating margin
    15.7 %     18.2 %     14.9 %     18.1 %
Depreciation and amortization
  $ 3,200     $ 2,885     $ 6,713     $ 5,838  
Capital expenditures
    652       954       1,914       2,600  
Dispensing Equipment
                               
Net sales
  $ 45,658     $ 56,601     $ 78,531     $ 106,609  
Operating income (d)
    10,021       14,256       14,000       25,500  
Operating margin
    21.9 %     25.2 %     17.8 %     23.9 %
Depreciation and amortization
  $ 886     $ 1,131     $ 1,670     $ 2,269  
Capital expenditures
    340       1,054       558       1,584  
Fire & Safety/Diversified
                               
Products Net sales
  $ 62,127     $ 77,247     $ 127,109     $ 145,910  
Operating income (d)
    13,738       18,828       27,309       36,558  
Operating margin
    22.1 %     24.4 %     21.5 %     25.1 %
Depreciation and amortization
  $ 1,248     $ 1,390     $ 2,528     $ 2,744  
Capital expenditures
    894       2,033       1,716       3,140  
Company
                               
Net sales
  $ 336,455     $ 397,310     $ 663,068     $ 768,972  
Operating income
    49,985       72,110       91,397       137,522  
Operating margin
    14.9 %     18.1 %     13.8 %     17.9 %
Depreciation and amortization (e)
  $ 14,164     $ 12,164     $ 27,758     $ 24,213  
Capital expenditures
    6,070       7,336       11,222       13,313  
 
 
(a)   Certain prior year amounts have been restated to reflect the LIFO to FIFO inventory costing change.
 
(b)   Adjusted to reflect the accounting guidance provided in FSP EITF 03-6, “Determining Whether Instruments Granted in Share-Based Payment Transactions are Participating Securities.”
 
(c)   Three and six month data includes acquisition of IETG (October 2008), iPEK (October 2008) and Richter (October 2008) in the Fluid & Metering Technologies Group and Semrock (October 2008) in the Health & Science Technologies Group from the date of acquisition.
 
(d)   Group operating income excludes unallocated corporate operating expenses and restructuring-related charges.
 
(e)   Excludes amortization of debt issuance expenses.

 

-----END PRIVACY-ENHANCED MESSAGE-----